Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | -522 | 0 | 3,444 | 1,216 | 1,493 |
| Gross Profit | -522 | N/A | 3,444 | 1,216 | 1,493 |
| Operating Expenses | 70,046 | -4,422 | 62,551 | 64,541 | 57,244 |
| Operating Income | -70,568 | -1,731 | -59,107 | -63,325 | -55,751 |
| Interest Expense | 1,948 | 1,880 | 1,727 | 1,501 | 912 |
| Other Income | 1,342 | 1,391 | 832 | 91 | 39 |
| Pre-tax Income | -71,174 | -2,220 | -60,002 | -64,735 | -56,624 |
| Net Income Continuous | -71,174 | -2,220 | -60,002 | -64,735 | -56,624 |
| Net Income | $-71,174 | $-68,796 | $-60,002 | $-64,735 | $-56,624 |
| EPS Basic Total Ops | -11.40 | -10.20 | -9.80 | -14.00 | -12.20 |
| EPS Basic Continuous Ops | -11.31 | 2.12 | -9.79 | -14.03 | -12.29 |
| EPS Diluted Total Ops | -11.40 | -10.20 | -9.80 | -14.00 | -12.20 |
| EPS Diluted Continuous Ops | -11.31 | 2.12 | -9.79 | -14.03 | -12.29 |
| EBITDA(a) | $-69,168 | $6,213 | $-57,006 | $-61,211 | $-53,735 |